{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:51:01Z","timestamp":1774533061285,"version":"3.50.1"},"reference-count":106,"publisher":"Informa UK Limited","issue":"18","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2015,12,12]]},"DOI":"10.1517\/14656566.2015.1114098","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T11:15:30Z","timestamp":1447931730000},"page":"2819-2833","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus"],"prefix":"10.1517","volume":"16","author":[{"given":"C","family":"Triplitt","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Solis-Herrera","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Cersosimo","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Abdul-Ghani","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph A","family":"Defronzo","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"e_1_3_1_2_1","volume-title":"Papers of special note have been highlighted as either of interest (\u2022) or of considerable interest (\u2022\u2022) to readers.","unstructured":"Papers of special note have been highlighted as either of interest (\u2022) or of considerable interest (\u2022\u2022) to readers."},{"key":"e_1_3_1_3_1","volume-title":"Centers for disease control and prevention: National diabetes report: estimates of diabetes and its burden in the United States, 2014","year":"2014","unstructured":"Centers for disease control and prevention: National diabetes report: estimates of diabetes and its burden in the United States, 2014. Atlanta (GA): US department of health and human services; 2014 [cited 2015 Jul 3]. Available from: www.cdc.gov\/diabetes\/data\/statistics\/2014statisticsreport.html"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0356"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12417"},{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0000000000000068"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.12.3273"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1213829"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2258"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2344"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP15693.CS"},{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2441"},{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2072"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70704"},{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72227"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1882"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.7.8770921"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/10606820213687"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02462.x"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2738-3"},{"key":"e_1_3_5_8_1","first-page":"188A","article-title":"Amylin inhibits pentagastrin-stimulated gastric acid secretion: comparison with glucagon-like peptide-1 and exendin-4 (abstract)","volume":"46","author":"Gedulin B","year":"1997","unstructured":"Gedulin B, Lawler R, Jodka C, et al. Amylin inhibits pentagastrin-stimulated gastric acid secretion: comparison with glucagon-like peptide-1 and exendin-4 (abstract). Diabetes. 1997;46:188A.","journal-title":"Diabetes"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802418851"},{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01565.x"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.14.6.782"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00055.2009"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0604"},{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00409.2012"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00439.2012"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01511.x"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.12.3427"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00007"},{"key":"e_1_3_7_7_1","first-page":"177","article-title":"Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes","volume":"5","author":"DeFronzo RA","year":"1997","unstructured":"DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews. 1997;5:177\u2013269.","journal-title":"Diabetes Reviews"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.667"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2004.04.013"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.9.4047"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.32.s3.5.x"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.6.610"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030723"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113157"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.10.2461"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197007162830301"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106297"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196906000-00008"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.34700"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.06.018"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2989"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02427280"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1342-6"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.47.2.159"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00274255"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7750"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116186"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69705-5"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00765.x"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.34.6.580"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-003-0079-9"},{"key":"e_1_3_7_32_1","first-page":"1778","article-title":"Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance","volume":"80","author":"Larsson H","year":"1995","unstructured":"Larsson H, Berglund G, Ahren B. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab. 1995;80:1778\u20131782.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100003"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050029"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197108192850806"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.5.785"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021545"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01545.x"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-012-0010-y"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04173.x"},{"key":"e_1_3_7_41_1","volume-title":"Tradjenta\u00ae [package insert]","year":"2014","unstructured":"Tradjenta\u00ae [package insert]. Ridgefield (CT), Boehringer Ingelheim Pharmaceuticals, 2014"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2365"},{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2364"},{"key":"e_1_3_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01350.x"},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399810666140214093600"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01590.x"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12308"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0706"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.06.008"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"e_1_3_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501352"},{"key":"e_1_3_11_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-3"},{"key":"e_1_3_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01517.x"},{"key":"e_1_3_11_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0473"},{"key":"e_1_3_11_5_1","volume-title":"Jardiance\u00ae [package insert]","year":"2015","unstructured":"Jardiance\u00ae [package insert]. Ridgefield (CT), Boehringer Ingelheim Pharmaceuticals; 2015 Jun."},{"key":"e_1_3_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12073"},{"key":"e_1_3_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70084-6"},{"key":"e_1_3_11_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2105"},{"key":"e_1_3_11_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2673"},{"key":"e_1_3_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12188"},{"key":"e_1_3_11_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-3055"},{"key":"e_1_3_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12307"},{"key":"e_1_3_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.01.040"},{"key":"e_1_3_11_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"e_1_3_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12322"},{"key":"e_1_3_12_3_1","unstructured":"Jardiance\u00ae (empagliflozin). Food and Drug Administration Center for Drug Evaluation and Research Application 2046orig1s000; [cited 2015 Jul 10]. Available from: www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204629Orig1s000RiskR.pdf"},{"key":"e_1_3_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70208-0"},{"key":"e_1_3_12_5_1","doi-asserted-by":"crossref","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","author":"Peters AL","year":"2015","unstructured":"Peters AL, Bruschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38:1687\u20131693.","journal-title":"Diabetes Care"},{"key":"e_1_3_12_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380"},{"key":"e_1_3_12_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0467"},{"key":"e_1_3_12_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1142"},{"key":"e_1_3_12_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1727"},{"key":"e_1_3_12_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1120"},{"key":"e_1_3_12_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.02941.x"},{"key":"e_1_3_12_12_1","doi-asserted-by":"crossref","first-page":"E1174","DOI":"10.1152\/ajpendo.00175.2011","article-title":"Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats","volume":"301","author":"Jamison RA","unstructured":"Jamison RA, Stark R, Dong J, et al. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats. Am J Physiol Endocrinol Metab. 2100;301:E1174\u2013E1183.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"e_1_3_12_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113157"},{"key":"e_1_3_12_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112981"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2015.1114098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:43:48Z","timestamp":1770403428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2015.1114098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":106,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,12,12]]}},"alternative-id":["10.1517\/14656566.2015.1114098"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2015.1114098","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}